Atlas Trials

Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer

Clinical trial NCT01848197 · UNKNOWN

Trial details

NCT number
NCT01848197
Sponsor
Taizhou Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerPaclitaxelEpirubicinCyclophosphamide
Start date
2013-05-01
Primary completion
2018-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.